Technology
American Public Education Reports First Quarter 2025 Financial Results
Published
12 months agoon
By
Net Income & Adjusted EBITDA Exceeded Guidance, Driven by Increased Enrollment and Operating Leverage in Rasmussen Segment
CHARLES TOWN, W.Va., May 12, 2025 /PRNewswire/ — American Public Education, Inc. (Nasdaq: APEI), a portfolio of education companies providing online and campus-based postsecondary education and career learning to over 125,000 students through four subsidiary institutions, has reported unaudited financial and operational results for the first quarter ended March 31, 2025.
Key First Quarter 2025 Highlights
Consolidated revenue for Q1 2025 increased 6.6% year-over-year to $164.6 million.Net income available to common stockholders in Q1 2025 was $7.5 million, compared to a net loss available to common stockholders of ($1.0) million in Q1 2024.Net income per diluted common share in Q1 2025 was $0.41, compared to net loss per diluted common share of ($0.06) in Q1 2024.Q1 2025 Adjusted EBITDA was $21.2 million compared to $17.1 million in Q1 2024.Increasing guidance for full year 2025 net income available to common stockholders to a range between $23 – $30 million and Adjusted EBITDA to a range between $77 million and $87 million. Full year 2025 revenue estimates of between $650 million and $660 million remain unchanged.
Management Commentary
“This first quarter of 2025 proved to be an excellent start to the year,” said Angela Selden, President and Chief Executive Officer of APEI. “We exceeded the expectations we set forth for the first quarter largely due to strong enrollment trends at Rasmussen which are beginning to show the operating leverage benefits of greater enrollment and disciplined operations.”
“The areas for improvements that we have focused on over the past two years are driving better and more consistent financial results. We have been able to deliver better results due to improved operations and student outcomes at our educational units, and we continue to educate service-minded professionals in high demand industries,” concluded Selden.
First Quarter 2025 Financial Results
Total consolidated revenue for the three months ended March 31, 2025, was $164.6 million, an increase of $10.1 million, or 6.6%, compared to $154.4 million for the three months ended March 31, 2024. The increase in revenue was primarily due to a $6.1 million increase in revenue in our Rasmussen University (“RU”) Segment, a $3.3 million increase in our American Public University System (“APUS”) Segment, and a $1.2 million increase in our Hondros College of Nursing (“HCN”) Segment.Total costs and expenses for the three months ended March 31, 2025, were $152.3 million, an increase of $3.1 million, or 2.0%, compared to $149.3 million for the three months ended March 31, 2024. The increase in costs and expenses for the three months ended March 31, 2025 was primarily driven by increases in employee compensation costs and advertising costs, partially offset by a decrease in information technology costs, and depreciation and amortization expenses.Instructional costs and services expenses for the three months ended March 31, 2025, were $74.9 million, an increase of $2.5 million, or 3.5%, compared to $72.4 million for the three months ended March 31, 2024.Selling and promotional expenses for the three months ended March 31, 2025, were $35.2 million, an increase of $2.7 million, or 8.5%, compared to $32.5 million for the three months ended March 31, 2024.General and administrative expenses for the three months ended March 31, 2025, were $36.4 million, an increase of $0.1 million, or 0.4%, compared to $36.3 million for the three months ended March 31, 2024. General and administrative expenses as a percentage of revenue decreased to 22.1% for the three months ended March 31, 2025, from 23.5% for the three months ended March 31, 2024.Net income available to common stockholders was $7.5 million, or $0.41 per diluted common share for the three months ended March 31, 2025, compared to a net loss of ($1.0) million, or ($0.06) per diluted common share, for the three months ended March 31, 2024.Adjusted EBITDA was $21.2 million for the three months ended March 31, 2025, compared to $17.1 million for the three months ended March 31, 2024. Adjusted EBITDA excludes adjustment for stock compensation, loss on disposals of long-lived assets, loss on assets held for sale, other professional fees and loss on leases.
Balance Sheet and Liquidity
Total cash, cash equivalents, and restricted cash were $187.5 million at March 31, 2025, compared to $158.9 million and December 31, 2024, representing an increase of $28.6 million, or 18.0%.
Registrations and Enrollment
Q1 2025
Q1 2024
% Change
American Public University System1
For the three months ended March 31,
Net Course Registrations
102,500
99,000
3.5 %
Rasmussen University2
For the three months ended March 31,
Total Student Enrollment
14,500
13,500
7.4 %
Hondros College of Nursing3
For the three months ended March 31,
Total Student Enrollment
3,600
3,300
9.6 %
APUS Net Course Registrations represents the approximate aggregate number of courses for which students remain enrolled after the date by which they may drop a course without financial penalty. Excludes students in doctoral programs.RU Total Student Enrollment represents students in an active status as of the full-term census or billing date.HCN Total Student Enrollment represents the approximate number of students enrolled in a course after the date by which students may drop a course without financial penalty.
Second Quarter and Full Year 2025 Outlook
The following statements are based on APEI’s current expectations. These statements are forward-looking and actual results may differ materially. APEI undertakes no obligation to update publicly any forward-looking statements for any reason unless required by law. Refer to APEI’s earnings conference call and presentation for further details.
Second Quarter 2025 Guidance
(Approximate)
(% Yr/Yr Change)
APUS Net course registrations
93,500 to 96,100
4% to 7%
HCN Student enrollment
3,700
14 %
RU Student enrollment
14,600
8 %
– On-ground Healthcare
6,400
3 %
– Online
8,300
12 %
($ in millions except EPS)
APEI Consolidated revenue
$160.0 – $162.0
4% to 5%
APEI Net loss/income available to common stockholders
($2.5) – ($0.7)
n.a.
APEI Adjusted EBITDA
$11.5 – $14.0
6% to 28%
APEI Diluted EPS
($0.13) – ($0.04)
n.a.
Full Year 2025 Guidance
(Approximate)
(% Yr/Yr Change)
($ in millions)
APEI Consolidated Revenue
$650 – $660
4% to 6%
APEI Net income available to common stockholders
$23 – $30
129% to 198%
APEI Adjusted EBITDA
$77 – $87
7% to 20%
APEI Capital Expenditure (CapEx)
$18 – $22
(14%) to 4%
Non-GAAP Financial Measures
This press release contains the non-GAAP financial measures of EBITDA (earnings before interest, taxes, depreciation, and amortization) and adjusted EBITDA (EBITDA less non-cash expenses such as stock compensation and non-recurring expenses). APEI believes that the use of these measures is useful because they allow investors to better evaluate APEI’s operating profit and cash generation capabilities.
For the three months ended March 31, 2025 and 2024, adjusted EBITDA excludes stock compensation, loss on disposals of long-lived assets, loss on assets held for sale, other professional fees and loss on leases.
These non-GAAP measures should not be considered in isolation or as an alternative to measures determined in accordance with generally accepted accounting principles in the United States (GAAP). The principal limitation of our non-GAAP measures is that they exclude expenses that are required by GAAP to be recorded. In addition, non-GAAP measures are subject to inherent limitations as they reflect the exercise of judgment by management about which expenses are excluded.
APEI is presenting EBITDA and adjusted EBITDA in connection with its GAAP results and urges investors to review the reconciliation of EBITDA and adjusted EBITDA to the comparable GAAP financial measures that is included in the tables following this press release (under the captions “GAAP Net Income to Adjusted EBITDA,” and “GAAP Outlook Net Income to Outlook Adjusted EBITDA”) and not to rely on any single financial measure to evaluate its business.
About American Public Education
American Public Education, Inc. (Nasdaq: APEI), through its institutions American Public University System, Rasmussen University, Hondros College of Nursing, and Graduate School USA, provides education that transforms lives, advances careers, and improves communities.
APUS, which operates through American Military University and American Public University, is the leading educator to active-duty military and veteran students* and serves approximately 88,000 adult learners worldwide via accessible and affordable higher education.
Rasmussen University is a 125-year-old nursing and health sciences-focused institution that serves approximately 14,600 students across its 20 campuses in six states and online. It also has schools of Business, Technology, Design, Early Childhood Education and Justice Studies.
Hondros College of Nursing focuses on educating pre-licensure nursing students at eight campuses (six in Ohio, one in Indiana, and one in Michigan). It is the largest educator of PN (LPN) nurses in the state of Ohio** and serves approximately 3,700 total students.
Graduate School USA is a leading training provider to the federal workforce with an extensive portfolio of government agency customers. It serves the federal workforce through customized contract training (B2G) to federal agencies and through open enrollment (B2C) to government professionals.
Both APUS and Rasmussen University are institutionally accredited by the Higher Learning Commission (HLC), an institutional accreditation agency recognized by the U.S. Department of Education. Hondros is accredited by the Accrediting Bureau of Health Education Schools (ABHES). Graduate School USA is accredited by the Accrediting Council for Continuing Education & Training (ACCET). For additional information, visit www.apei.com.
*Based on FY 2019 Department of Defense tuition assistance data, as reported by Military Times, and Veterans Administration student enrollment data as of 2024.
**Based on information compiled by the National Council of State Boards of Nursing and Ohio Board of Nursing.
Forward Looking Statements
Statements made in this press release regarding APEI or its subsidiaries that are not historical facts are forward-looking statements based on current expectations, assumptions, estimates and projections about APEI and the industry. In some cases, forward-looking statements can be identified by words such as “anticipate,” “believe,” “seek,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “should,” “will,” “would,” and similar words or their opposites. Forward-looking statements include, without limitation, statements regarding the Company’s future path, expected growth, registration, enrollments, revenues, net income, Adjusted EBITDA and EBITDA, capital expenditures, the growth and profitability of Rasmussen University and plans with respect to recent, current and future initiatives.
Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Such risks and uncertainties include, among others, risks related to: APEI’s failure to comply with regulatory and accrediting agency requirements, including the “90/10 Rule”, and to maintain institutional accreditation and the impacts of any actions APEI may take to prevent or correct such failure; changes in the postsecondary education regulatory environment as a result of U.S. federal elections, including any changes by or as a result of actions of the current administration to the operations of the Department of Education or changes to or the elimination or implementation of laws, regulations, standards, policies, and practices; potential or actual government shutdowns; the impact, timing, and projected benefits of the planned combination of APUS, RU, and HCN into one consolidated institution; APEI’s dependence on the effectiveness of its ability to attract students who persist in its institutions’ programs; changing market demands; declines in enrollments at APEI’s subsidiaries; APEI’s inability to effectively market its institutions’ programs; APEI’s inability to maintain strong relationships with the military and maintain course registrations and enrollments from military students; the loss or disruption of APEI’s ability to receive funds under Title IV or tuition assistance programs or the reduction, elimination, or suspension of federal funds; adverse effects of changes APEI makes to improve the student experience and enhance the ability to identify and enroll students who are likely to succeed; APEI’s need to successfully adjust to future market demands by updating existing programs and developing new programs; APEI’s loss of eligibility to participate in Title IV programs or ability to process Title IV financial aid; economic and market conditions and changes in interest rates; difficulties involving acquisitions; APEI’s indebtedness and preferred stock, including the refinancing or redemption thereof; APEI’s dependence on and the need to continue to invest in its technology infrastructure, including with respect to third-party vendors; the inability to recognize the anticipated benefits of APEI’s cost savings and revenue generating efforts; APEI’s ability to manage and limit its exposure to bad debt; and the various risks described in the “Risk Factors” section and elsewhere in APEI’s Annual Report on Form 10-K for the year ended March 31, 2025, and in other filings with the SEC. You should not place undue reliance on any forward-looking statements. APEI undertakes no obligation to update publicly any forward-looking statements for any reason, unless required by law, even if new information becomes available or other events occur in the future.
Company Contact
Frank Tutalo
Director, Public Relations
American Public Education, Inc.
ftutalo@apei.com
571-358-3042
Investor Relations
Brian M. Prenoveau, CFA
MZ North America
Direct: 561-489-5315
APEI@mzgroup.us
American Public Education, Inc.
Consolidated Balance Sheet
(In thousands)
As of March 31, 2025
As of December 31, 2024
ASSETS
(Unaudited)
Current assets:
Cash, cash equivalents, and restricted cash
$
187,502
$
158,941
Accounts receivable, net of allowance of $19,547 in 2025 and
$19,280 in 2024
41,872
62,465
Prepaid expenses
20,667
13,748
Income tax receivable
–
949
Assets held for sale
22,467
24,469
Total current assets
272,508
260,572
Property and equipment, net
73,038
73,383
Operating lease assets, net
92,649
94,776
Deferred income taxes
46,066
47,311
Intangible assets, net
28,221
28,221
Goodwill
59,593
59,593
Other assets, net
6,586
6,247
Total assets
$
578,661
$
570,103
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
$
7,849
$
7,847
Accrued compensation and benefits
18,039
20,546
Accrued liabilities
18,790
13,735
Deferred revenue and student deposits
25,087
23,474
Income tax payable
177
–
Lease liabilities, current
13,489
13,553
Total current liabilities
83,431
79,155
Lease liabilities, long-term
91,471
93,645
Long-term debt, net
93,747
93,424
Total liabilities
$
268,649
$
266,224
Stockholders’ equity:
Preferred stock, $.01 par value; 10,000,000 shares authorized; 400
shares issued and outstanding in 2025 and 2024, respectively
($112,471 and $117,439 liquidation preference per share, $44,988
and $46,976 in aggregate, for 2025 and 2024, respectively)
39,691
39,691
Common stock, $.01 par value; 100,000,000 shares authorized;
18,036,421 issued and outstanding in 2025; 17,712,575 issued and
outstanding in 2024
180
177
Additional paid-in capital
304,533
305,823
Accumulated other comprehensive loss
(48)
(7)
Accumulated deficit
(34,344)
(41,805)
Total stockholders’ equity
310,012
303,879
Total liabilities and stockholders’ equity
$
578,661
$
570,103
American Public Education, Inc.
Consolidated Statement of Income
(In thousands, except per share data)
Three Months Ended
March 31,
2025
2024
(unaudited)
Revenue
$
164,551
$
154,432
Costs and expenses:
Instructional costs and services
74,944
72,425
Selling and promotional
35,205
32,456
General and administrative
36,407
36,277
Depreciation and amortization
3,992
5,128
Loss on assets held for sale
1,527
–
Loss on leases
–
2,936
Loss on disposals of long-lived assets
230
28
Total costs and expenses
152,305
149,250
Income from operations before
interest and income taxes
12,246
5,182
Interest expense, net
(887)
(126)
Income before income taxes
11,359
5,056
Income tax expense
2,466
1,213
Equity investment loss
–
(3,327)
Net income
$
8,893
$
516
Preferred stock dividends
1,432
1,535
Net income (loss) available to common stockholders
$
7,461
$
(1,019)
Income (loss) per common share:
Basic
$
0.42
$
(0.06)
Diluted
$
0.41
$
(0.06)
Weighted average number of
common shares:
Basic
17,840
17,510
Diluted
18,417
17,811
Three Months Ended
Segment Information:
March 31,
2025
2024
Revenue:
APUS Segment
$
83,946
$
80,656
RU Segment
$
59,251
$
53,135
HCN Segment
$
17,676
$
16,447
Corporate and other1
$
3,678
$
4,194
Income (loss) from operations before
interest and income taxes:
APUS Segment
$
24,126
$
23,087
RU Segment
$
(72)
$
(8,966)
HCN Segment
$
(746)
$
(304)
Corporate and other
$
(11,062)
$
(8,635)
1. Corporate and Other includes tuition and contract training revenue earned by GSUSA and the elimination of intersegment revenue for courses taken by employees of one segment at other segments.
GAAP Net Income to Adjusted EBITDA:
The following table sets forth the reconciliation of
the Company’s reported GAAP net income to the
calculation of adjusted EBITDA for the three
months ended March 31, 2025 and 2024:
Three Months Ended
March 31,
(in thousands, except per share data)
2025
2024
Net income (loss) available to common stockholders
$
7,461
$
(1,019)
Preferred dividends
1,432
1,535
Net income
$
8,893
$
516
Income tax expense
2,466
1,213
Interest expense, net
887
126
Equity investment loss
–
3,327
Depreciation and amortization
3,992
5,128
EBITDA
16,238
10,310
Loss on assets held for sale
1,527
–
Loss on leases
–
2,936
Other professional fees
989
–
Stock compensation
2,263
1,918
Loss on disposals of long-lived assets
230
28
Transition services costs
–
1,865
Adjusted EBITDA
$
21,247
$
17,057
GAAP Outlook Net Income to Outlook Adjusted EBITDA:
The following table sets forth the reconciliation of the
Company’s outlook GAAP net income to the calculation
of outlook adjusted EBITDA for the three months ending
June 30, 2025 and twelve months ending December 31,
2025:
Three Months Ending
Twelve Months Ending
June 30, 2025
December 31, 2025
(in thousands, except per share data)
Low
High
Low
High
Net income/(loss) available to common stockholders
$
(2,461)
$
(711)
$
22,937
$
29,937
Preferred dividends
1,488
1,488
2,920
2,920
Net Income/(Loss)
(973)
777
25,857
32,857
Income tax expense/(benefit)
(417)
333
11,082
14,082
Interest expense
4,127
4,127
7,852
7,852
Depreciation and amortization
4,459
4,459
17,986
17,986
EBITDA
7,196
9,696
62,777
72,777
Stock compensation
2,254
2,254
7,349
7,349
Professional Services
1,688
1,688
3,953
3,953
Transition services cost
363
363
1,164
1,164
Other
–
1,757
1,757
Adjusted EBITDA
$
11,500
$
14,000
$
77,000
$
87,000
EPS
$
(0.13)
$
(0.04)
$
1.23
$
1.61
View original content to download multimedia:https://www.prnewswire.com/news-releases/american-public-education-reports-first-quarter-2025-financial-results-302452808.html
SOURCE American Public Education, Inc.
You may like
Technology
VERNAL CAPITAL ACQUISITION CORP. ANNOUNCES PRICING OF $100 MILLION INITIAL PUBLIC OFFERING
Published
2 hours agoon
May 6, 2026By
NEW YORK, May 5, 2026 /PRNewswire/ — Vernal Capital Acquisition Corp. (NYSE: VECA) (“Vernal”) announced the pricing of its initial public offering (the “IPO”) of 10,000,000 units at $10.00 per unit. The units are expected to trade on the New York Stock Exchange (“NYSE”) under “VECAU” beginning May 6, 2026. Each unit consists of one ordinary share and one right to receive one-fourth of one ordinary share upon consummation of an initial business combination. Upon separate trading, the ordinary shares and rights are expected to be listed on NYSE under “VECA” and “VECAR,” respectively.
D. Boral Capital LLC is acting as sole book-running manager of the offering. The underwriters have a 45-day option to purchase up to 1,500,000 additional units to cover any over-allotments. The offering is expected to close on May 7, 2026, subject to customary closing conditions.
A registration statement for these securities was declared effective by the SEC on May 5, 2026. The offering is made only by means of a prospectus. Copies of the prospectus may be obtained, from D. Boral Capital LLC, 590 Madison Ave., 39th Floor, New York, New York 10022, by telephone at (212) 970-5150 or by email at dbccapitalmarkets@dboralcapital.com.
This press release shall not constitute an offer to sell or to buy, nor shall there be any sale where such offer, solicitation or sale would be unlawful prior to registration or qualification under the applicable securities laws.
About Vernal
Vernal is a blank check company formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Vernal’s target search will not be limited to a particular industry or geographic region.
Forward-Looking Statements
This press release contains “forward-looking statements,” including statements regarding Vernal’s IPO. These statements are subject to risks and uncertainties that could cause actual results to differ materially. No assurance can be given that the offering will be completed on the terms described, or at all. Forward-looking statements are subject to numerous conditions, beyond Vernal’s control, including those in the Risk Factors section of Vernal’s registration statement filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. Vernal disclaims any obligation to release publicly updates or revisions to any forward-looking statements to reflect any change in Vernal’s expectations, except as required by law.
Contact
Binghan Yi, CFO
binghan@vernal.com
www.vernalspac.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/vernal-capital-acquisition-corp-announces-pricing-of-100-million-initial-public-offering-302763378.html
SOURCE Vernal Capital Acquisition Corp.
Technology
RIVANNA nominated for MedTech Scale-Up of the Year at MedTech World Awards 2026 | North America
Published
3 hours agoon
May 5, 2026By
Nomination places the Charlottesville-based company among growth-stage medtech leaders recognized for commercial momentum in AI-powered clinical decision support; public voting is open through May 8
CHARLOTTESVILLE, Va., May 5, 2026 /PRNewswire/ — RIVANNA®, developer of AI-powered clinical decision-support solutions, today announced that it has been nominated for MedTech Scale-Up of the Year at the MedTech World Awards 2026 | North America. Public voting is open through Friday, May 8, 2026, with category winners to be announced at the inaugural North American Awards Gala on May 11, 2026, at the Hilton West Palm Beach in Florida.
The MedTech Scale-Up of the Year category honors a growth-stage company successfully scaling revenues, partnerships, and adoption across the global medical technology ecosystem. Nominees across the program’s 22 categories were selected through a structured process led by the MedTech World Steering Committee, with category winners determined by a combination of expert evaluation and public voting from the global MedTech community.
“We have built RIVANNA on validation earned from the most rigorous technical buyers in healthcare: competitive federal awards translated into FDA-cleared products, each paired with a commercial program that meets clinicians where they work,” said Will Mauldin, PhD, Co-founder and CEO of RIVANNA. “Being nominated for MedTech Scale-Up of the Year is a meaningful affirmation of that approach and the team executing it.”
Public voting closes Friday, May 8, 2026. Members of the MedTech community are invited to support RIVANNA’s nomination at the official voting page: vote here.
The award nomination follows a year of measurable scaling for RIVANNA:
In October 2025, RIVANNA reported on being named a finalist in MedTech Innovator’s 2025 Early-Stage Grand Prize competition, selected from nearly 1,500 global applicants to represent the top 4% of medtech innovations worldwide.In December 2025, RIVANNA reported on the U.S. Food and Drug Administration’s 510(k) clearance of its Accuro® 3S Needle Guide Kit consumables, building on existing Accuro 3S device clearance.In April 2026, RIVANNA reported on peer-reviewed findings, published in 2025 in the Journal of Emergency Medicine (DOI: 10.1016/j.jemermed.2025.11.011), showing that the Accuro® XV musculoskeletal imaging system enables non-physician operators to acquire diagnostic-quality scans after just one hour of hands-on training.In May 2026, RIVANNA reported on the U.S. Food and Drug Administration’s 510(k) clearance of the Accuro® XV Diagnostic Ultrasound System for musculoskeletal imaging, authorizing commercial use across hospital and clinic settings.The company’s clinical program now spans eight sites nationwide with more than 1,500 patients enrolled.
The 2026 MedTech World Awards | North America, powered by Blue Goat Cyber, will be presented Monday, May 11, 2026, at the inaugural North American Awards Gala at the Hilton West Palm Beach, marking the first time the MedTech World Awards have been hosted in the United States.
About the MedTech Scale-Up of the Year Award
Presented by MedTech World, the MedTech Scale-Up of the Year category recognizes growth-stage medical technology companies demonstrating strong commercial momentum, expanding partnerships, and accelerating real-world adoption. The award is one of 22 categories spanning innovation, clinical excellence, regulatory strategy, investment, and leadership across the global MedTech ecosystem.
About RIVANNA
RIVANNA® is a medical technology company developing clinical decision-support solutions powered by proprietary clinical datasets, AI models, and purpose-built imaging hardware. The company’s platform automates complex anatomical analysis at the point of care, enabling faster, more confident clinical decisions while reducing variability and expanding access to advanced capabilities. The first applications target significant market opportunities in regional anesthesia and fracture care. RIVANNA has built a proven FDA regulatory track record across its Accuro® platform, with device clearances for Accuro® 3S (spinal needle guidance) and Accuro® XV (musculoskeletal imaging), a portfolio of supporting cleared consumables, and AI software modules advancing through regulatory review. The company is backed by 100+ patents and validated through clinical partnerships with leading academic medical centers. RIVANNA is headquartered in Charlottesville, Virginia, and operates an FDA-registered, ISO 13485:2016-certified manufacturing facility. Learn more at rivannamedical.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/rivanna-nominated-for-medtech-scale-up-of-the-year-at-medtech-world-awards-2026–north-america-302763342.html
SOURCE RIVANNA
Technology
D2L Launch Week Highlights Latest Product Releases
Published
3 hours agoon
May 5, 2026By
Latest innovations are designed to save time, simplify workflows, and help drive better learning outcomes
TORONTO, May 5, 2026 /PRNewswire/ – D2L, a global leader in learning innovation, hosted its first-ever D2L Launch Week, a four-day virtual webinar series spotlighting the company’s latest product innovations across D2L Brightspace in 2026.
Throughout the week, D2L showcased a range of product releases through live demos and practical customer use cases, highlighting how institutions, school districts and organizations can help to drive engagement and improve learning outcomes. The featured updates include enhancements to D2L Lumi for idea generation, intervention suggestions, quiz creation and summarization; tools to strengthen parent and guardian outreach; and administrative capabilities designed to help large organizations delegate course and configuration management more effectively.
“We’re proud to showcase the ways D2L continues to innovate to help make learning more personalized, efficient, and scalable,” said Christian Pantel, Chief Product Officer at D2L. “From new D2L Lumi features to enhanced communication tools and more flexible distributed administration capabilities, these updates are designed to help our customers save time, improve usability, and deliver better learning experiences at scale.”
Enhancements to D2L Lumi
Among the new capabilities were several updates to D2L’s AI-native tool, D2L Lumi, designed to improve usability, transparency, and alignment across workflows, including:
D2L Lumi Ideas: Generates assignment and discussion ideas directly within Brightspace, making it easier to generate high quality content aligned to learning outcomes.D2L Lumi Insights: Gives educators access to learning intervention suggestions, designed to provide recommended next steps based on learner data.D2L Lumi Quiz: Helps educators generate questions from multiple course content topics and includes a more streamlined question-generation workflow.D2L Lumi Summary: Supports summarization from more content sources, including nested submodules, and can give educators the ability to preview and adjust source text before summarization.
Updates to Parent and Guardian Communications
D2L also introduced new parent and guardian communication enhancements to help K-12 educators strengthen engagement beyond the classroom. Teachers can now send bulk emails to all parents and guardians associated with students in their class. For individual student outreach, teachers can also email parents and guardians of a specific learner, making it easier to share timely updates on student progress and classroom activity.
Manage Distributed Administration at Scale
Distributed Administration gives organizations more flexibility to delegate administrative responsibilities across organization levels. With Distributed Administration, administrators can manage specific areas, enabling them to oversee courses while helping to reduce bottlenecks and free up time.
Learn more about the latest product releases showcased at D2L Launch Week.
About D2L
D2L is transforming the way the world learns, helping learners achieve more than they dreamed possible. Working closely with customers all over the world, D2L is on a mission to make learning more inspiring, engaging and human. Find out how D2L helps transform lives and delivers outstanding learning outcomes in K-12, higher education and businesses.
D2L Media Contact
PR@D2L.com
X: @D2L
© 2026 D2L Corporation.
The D2L family of companies includes D2L Inc., D2L Corporation, D2L Ltd, D2L Australia Pty Ltd, D2L Europe Ltd, D2L Asia Pte Ltd, D2L India Pvt Ltd, D2L Brasil Soluções de Tecnologia para Educação Ltda and D2L Sistemas de Aprendizaje Innovadores, S. D2 R.L de C.V., and H5P Group AS.
All D2L and H5P marks are owned by the D2L group of companies. Please visit D2L.com/trademarks for a list of D2L marks. All other trademarks are the property of their respective owners.
View original content to download multimedia:https://www.prnewswire.com/news-releases/d2l-launch-week-highlights-latest-product-releases-302763345.html
SOURCE D2L
NEAR Origin Story Part 2
NEAR Origin Story Part 2
VERNAL CAPITAL ACQUISITION CORP. ANNOUNCES PRICING OF $100 MILLION INITIAL PUBLIC OFFERING
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
New Gooseneck Omni Antennas Offer Enhanced Signals in a Durable Package
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Technology4 days agoRoyal Visit to Front Royal: Randolph-Macon Academy Shines at Block Party for King Charles III and Queen Camilla
-
Coin Market4 days ago
CLARITY Act stablecoin yield rules finalised: ‘Go time’ for crypto bill
-
Technology4 days agoManufacturing PMI® at 52.7%; April 2026 ISM® Manufacturing PMI® Report
-
Technology4 days agoFirst Online Conversations Are Changing in 2026, According to New Secretmeet Research
-
Coin Market5 days ago
Bitcoin risks extended retreat as April rally was futures-driven: CryptoQuant
-
Coin Market5 days ago
SBI eyes Bitbank deal as Japan’s crypto exchange market consolidates
-
Coin Market4 days agoThree Bitcoin data points suggest a rally to $80K is imminent
-
Technology4 days agoProducts That Count Announces the Winners of the 2026 CPO Awards, Honoring the Product Leaders Redefining Their Craft in the AI Era
